Wikidata

(Q61914676)

English

Vorinostat (MK-0683, SAHA [Suberoylanilide Hydroxamic Acid]) + Lenalidomide + Dexamethasone in Multiple Myeloma (MM) (MK-0683-074)

clinical trial

In more languages

Statements

title
A Phase I Study of Vorinostat in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma (English)
0 references
start time
February 2008
0 references
end time
September 2012
0 references
number of participants
31
0 references
research intervention
dexamethasone acetate
0 references
(RS)-cyclophosphamide
0 references
(RS)-lenalidomide
0 references
vorinostat
0 references
thalidomide
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61914676&oldid=2108122831"